• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞病视盘的新生血管形成。

Neovascularization of the optic disc in Behçet's disease.

作者信息

Tugal-Tutkun Ilknur, Onal Sumru, Altan-Yaycioglu Rana, Kir Nur, Urgancioglu Meri

机构信息

Department of Ophthamology, Istanbul University, Istanbul Faculty of Medicine, Turkey.

出版信息

Jpn J Ophthalmol. 2006 May-Jun;50(3):256-65. doi: 10.1007/s10384-005-0307-8.

DOI:10.1007/s10384-005-0307-8
PMID:16767382
Abstract

PURPOSE

To investigate the mechanisms involved in the development of neovascularization of the optic disc (NVD) in Behçet's disease and to evaluate the effects of medical and laser treatments.

METHODS

This is a retrospective study of 26 consecutive Behçet's patients (38 eyes) with NVD who presented between 1990 and 2004 at our university hospital. Information on age at presentation, sex, disease duration, laterality of NVD, ocular findings, fluorescein angiographic findings, visual acuity, medical treatment, laser photocoagulation, surgical procedures, and the follow-up period was collected. Eyes with diffuse capillary leakage on fluorescein angiography were defined as having inflammation-induced NVD, and eyes with extensive retinal capillary nonperfusion were defined as having ischemia-induced NVD.

RESULTS

Eighteen patients were male, and eight were female. Mean age at presentation was 25.4 +/- 4.9 years. Median disease duration was 5.5 months. Median follow-up was 24 months. Twelve patients had bilateral NVD; 14 had unilateral NVD. Inflammation-induced NVD was seen in 87% of the eyes, and ischemia-induced NVD in 13%. Initial treatment with high-dose corticosteroids combined with conventional immunosuppressive agents was effective in 45% of the eyes with inflammation-induced NVD. Retinal laser photocoagulation was effective in three of five eyes with ischemia-induced NVD. Treatment with interferon alpha-2a resulted in resolution of NVD in all seven patients who received this agent for inflammation- or ischemia-induced persistent NVD. Final visual acuity was less than 0.1 in 24% of the eyes.

CONCLUSIONS

Inflammatory mechanisms seem to predominate in the pathogenesis of NVD in Behçet's disease. The results of this study suggest that the response to intensive anti-inflammatory and conventional immunosuppressive treatment is not satisfactory; retinal laser photocoagulation may be ineffective even in eyes with retinal ischemia, but interferon alpha-2a seems to be effective for the treatment of Behçet's patients with NVD.

摘要

目的

研究白塞病视盘新生血管形成(NVD)的发病机制,并评估药物及激光治疗的效果。

方法

这是一项对1990年至2004年间在我校医院就诊的26例连续白塞病患者(38只眼)合并NVD的回顾性研究。收集了患者就诊时的年龄、性别、病程、NVD的单侧或双侧情况、眼部表现、荧光素血管造影结果、视力、药物治疗、激光光凝、手术操作及随访时间等信息。荧光素血管造影显示弥漫性毛细血管渗漏的眼被定义为炎症性NVD,视网膜毛细血管广泛无灌注的眼被定义为缺血性NVD。

结果

18例为男性,8例为女性。就诊时的平均年龄为25.4±4.9岁。病程中位数为5.5个月。随访中位数为24个月。12例患者为双侧NVD;14例为单侧NVD。87%的眼为炎症性NVD,13%为缺血性NVD。高剂量皮质类固醇联合传统免疫抑制剂的初始治疗对45%的炎症性NVD眼有效。视网膜激光光凝对5只缺血性NVD眼中的3只有效。干扰素α-2a治疗使所有7例因炎症性或缺血性持续性NVD接受该药物治疗的患者的NVD消退。24%的眼最终视力低于0.1。

结论

炎症机制似乎在白塞病NVD的发病机制中占主导地位。本研究结果表明,强化抗炎和传统免疫抑制治疗的反应并不令人满意;视网膜激光光凝即使在视网膜缺血的眼中也可能无效,但干扰素α-2a似乎对白塞病合并NVD的患者有效。

相似文献

1
Neovascularization of the optic disc in Behçet's disease.白塞病视盘的新生血管形成。
Jpn J Ophthalmol. 2006 May-Jun;50(3):256-65. doi: 10.1007/s10384-005-0307-8.
2
Retinal and disc neovascularization in Behçet's disease and efficacy of laser photocoagulation.白塞病中的视网膜和视盘新生血管形成以及激光光凝术的疗效
Graefes Arch Clin Exp Ophthalmol. 1996 Feb;234(2):94-9. doi: 10.1007/BF00695247.
3
Regression of optic disc neovascularization in patients with Behçet's uveoretinitis after infliximab therapy.贝赫切特葡萄膜炎患者接受英夫利昔单抗治疗后视盘新生血管消退。
J Ocul Pharmacol Ther. 2010 Dec;26(6):627-30. doi: 10.1089/jop.2010.0031. Epub 2010 Nov 2.
4
Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy.英夫利昔单抗治疗贝赫切特病患者的眼部炎症发作减少及眼底视网膜和视盘血管渗漏减轻。
Br J Ophthalmol. 2011 Sep;95(9):1245-50. doi: 10.1136/bjo.2010.194464. Epub 2010 Dec 22.
5
Results of interferon alpha-2a therapy in patients with Behcet's disease.干扰素 α-2a 治疗白塞病患者的结果。
J Ocul Pharmacol Ther. 2012 Aug;28(4):439-43. doi: 10.1089/jop.2011.0238. Epub 2012 Mar 28.
6
Tractional retinal detachment after branch retinal vein occlusion. Influence of disc neovascularization on the outcome of vitreous surgery.视网膜分支静脉阻塞后的牵引性视网膜脱离。视盘新生血管对玻璃体手术结果的影响。
Ophthalmology. 1998 Mar;105(3):417-23. doi: 10.1016/S0161-6420(98)93021-4.
7
Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments.干扰素 α-2a 治疗常规治疗抵抗的 Behçet 葡萄膜炎患者的安全性和有效性。
Ophthalmology. 2010 Jul;117(7):1430-5. doi: 10.1016/j.ophtha.2009.11.022. Epub 2010 Apr 24.
8
Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.用干扰素α2a治疗白塞病眼部症状:一项试点研究。
Br J Ophthalmol. 1998 May;82(5):488-94. doi: 10.1136/bjo.82.5.488.
9
Spectrum of Behçet's disease in the Indian population.印度人群中的白塞病谱系
Int Ophthalmol. 2009 Dec;29(6):495-501. doi: 10.1007/s10792-008-9273-8. Epub 2008 Oct 21.
10
Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
Ophthalmology. 1993 Nov;100(11):1655-64. doi: 10.1016/s0161-6420(93)31421-1.

引用本文的文献

1
Vitreous hemorrhage in patients with uveitis: a comparative study between adults and children.葡萄膜炎患者的玻璃体积血:成人与儿童的比较研究
Int Ophthalmol. 2025 Feb 7;45(1):60. doi: 10.1007/s10792-024-03403-3.
2
Behçet uveitis: Current practice and future perspectives.白塞氏葡萄膜炎:当前实践与未来展望。
Front Med (Lausanne). 2022 Sep 7;9:968345. doi: 10.3389/fmed.2022.968345. eCollection 2022.
3
Fluorescein angiographic findings and Behcet's disease ocular attack score 24 (BOS24) as prognostic factors for visual outcome in patients with ocular Behcet's disease.

本文引用的文献

1
Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease.英夫利昔单抗治疗白塞病伴视网膜新生血管的后葡萄膜炎
Eur J Ophthalmol. 2004 Sep-Oct;14(5):445-8.
2
Uveitis in Behçet disease: an analysis of 880 patients.白塞病中的葡萄膜炎:880例患者的分析
Am J Ophthalmol. 2004 Sep;138(3):373-80. doi: 10.1016/j.ajo.2004.03.022.
3
Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease.英夫利昔单抗用于治疗复发性、威胁视力的白塞病眼部炎症。
荧光素血管造影结果和白塞病眼部发作评分24(BOS24)作为白塞病性葡萄膜炎患者视力预后的预测因素。
Int J Retina Vitreous. 2021 Aug 28;7(1):48. doi: 10.1186/s40942-021-00318-4.
4
Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.贝赫切特葡萄膜炎:当前的诊断与治疗方法。
Turk J Ophthalmol. 2020 Jun 27;50(3):169-182. doi: 10.4274/tjo.galenos.2019.60308.
5
Topical interferon alpha 2b in the treatment of refractory pseudophakic cystoid macular edema.局部应用干扰素α-2b治疗难治性人工晶状体性黄斑囊样水肿。
Am J Ophthalmol Case Rep. 2018 Mar 7;10:203-205. doi: 10.1016/j.ajoc.2018.03.005. eCollection 2018 Jun.
6
Inflammatory optic disc neovascularisation managed with oral steroids/immunosuppressants and intravitreal ranibizumab.采用口服类固醇/免疫抑制剂及玻璃体内注射雷珠单抗治疗炎症性视盘新生血管形成。
BMJ Case Rep. 2017 Nov 3;2017:bcr-2017-222262. doi: 10.1136/bcr-2017-222262.
7
Risk of Retinal Neovascularization in Cases of Uveitis.葡萄膜炎患者视网膜新生血管形成的风险
Ophthalmology. 2016 Mar;123(3):646-54. doi: 10.1016/j.ophtha.2015.10.056. Epub 2015 Dec 11.
8
Ischemic retinal vasculitis and its management.缺血性视网膜血管炎及其治疗
J Ophthalmol. 2014;2014:197675. doi: 10.1155/2014/197675. Epub 2014 Apr 15.
9
Ocular manifestations of Behçet's disease in Jordanian patients.约旦患者白塞病的眼部表现
Saudi J Ophthalmol. 2013 Oct;27(4):247-51. doi: 10.1016/j.sjopt.2013.06.012. Epub 2013 Jul 1.
10
Cellular debris in the anterior vitreous in silent eyes of behçet patients as a clue of asymptomatic ocular involvement.白塞病患者安静眼的前玻璃体中的细胞碎片作为无症状眼部受累的线索。
J Ophthalmol. 2013;2013:398054. doi: 10.1155/2013/398054. Epub 2013 Oct 3.
Ann Intern Med. 2004 Mar 2;140(5):404-6. doi: 10.7326/0003-4819-140-5-200403020-00025.
4
Childhood-onset uveitis in Behçet disease:a descriptive study of 36 cases.白塞病中的儿童期起病葡萄膜炎:36例描述性研究
Am J Ophthalmol. 2003 Dec;136(6):1114-9. doi: 10.1016/s0002-9394(03)00791-8.
5
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.人重组干扰素α-2a用于治疗伴有威胁视力的后部或全葡萄膜炎的白塞病。
Br J Ophthalmol. 2003 Apr;87(4):423-31. doi: 10.1136/bjo.87.4.423.
6
The interferon system: an overview.干扰素系统:概述
Eur J Paediatr Neurol. 2002;6 Suppl A:A41-6; discussion A55-8. doi: 10.1053/ejpn.2002.0573.
7
Complete regression of retinal neovascularization after therapy with interferon alfa in Behçet's disease.白塞病患者接受干扰素α治疗后视网膜新生血管完全消退。
Br J Ophthalmol. 2000 Dec;84(12):1437-8. doi: 10.1136/bjo.84.12.1432g.
8
Corticosteroid therapy for optic disc neovascularization secondary to chronic uveitis.皮质类固醇疗法治疗慢性葡萄膜炎继发的视盘新生血管化。
Am J Ophthalmol. 2000 Dec;130(6):724-31. doi: 10.1016/s0002-9394(00)00598-5.
9
Retinal and disc neovascularization in Behçet's disease and efficacy of laser photocoagulation.白塞病中的视网膜和视盘新生血管形成以及激光光凝术的疗效
Graefes Arch Clin Exp Ophthalmol. 1996 Feb;234(2):94-9. doi: 10.1007/BF00695247.
10
Resolution of optic disk neovascularization associated with intraocular inflammation.
Am J Ophthalmol. 1980 Oct;90(4):545-8. doi: 10.1016/s0002-9394(14)75026-3.